http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2145154-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-08 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F5-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C35-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C35-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C33-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C33-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F5-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C17-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F5-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-32 |
| filingDate | 1971-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1972-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-2145154-A1 |
| titleOfInvention | Indanyl, naphthyl and benzosuberanyl derivatives, their pharmacologically acceptable salts with acids, quaternary ammonium salts and N-oxides, processes for their preparation and pharmaceuticals |
| abstract | 1375732 Bicyclic cycloaliphatic aminoalcohols and derivatives thereof E R SQUIBB & SONS Inc 10 Sept 1971 [10 Sept 1970] 40337/71 Heading C2C The invention comprises compounds of formulµ wherein R 1 , R 2 , R 3 and R 4 are each H, C 1-8 alkyl or haloalkyl, acyl, amido, (C 1-8 alkoxy)alkyl or (C 1-8 alkoxy)carbonyl; X is a single bond or a C 1-10 straight or branched chain divalent radical; Y is NR 5 R 6 where R 5 and R 6 are each H, C 1-8 alkyl, haloalkyl, alkoxy, hydroxyalkyl, alka. noyl or haloalkanoyl, (monocyclic) cycloalkyl or cycloalkyl-alkyl, (monocyclic)aryl, aroyl or aryl-C 1-8 alkyl, (monocyclic) heterocyclyl or heterocyclyl-alkyl, or N,N-dialkylsulphamoyl, or NR 5 R 6 may be heterocyclyl; R 8 , R 1 8 are each C 1-8 alkyl or cycloalkyl; m, m 1 are each 0-2, and n is 1-3. In examples, which generally specify the particular stereoisomers isolated, these compounds are prepared by (1) oxidation (if necessary first protecting a primary amine by making the acylamino compound) of the corresponding 4,7-dihydro-, 4,5,6,7-tetrahydro-, or 3a,4,7,7a-tetrahydro-indones (or the analogous naphthalene or benzocycloheptene derivatives), and if H 2 O 2 /HCO 2 H is used, hydrolysis of the intermediate ester mixture to the diol or tetrol; (2) O-acylation; (3) hydrolysis of esters or amides; (4) hydrogenolysis of a compound where R 5 is PhCH 2 to give R 5 =H. Intermediates otherwise prepared are indene, indane, tetralin, 1,2-dihydronaphthalene and benzocycloheptene precursors of the abovementioned dihydro- and tetrahydro-amino compounds; 1-(2-hydroxyethyl)indene, 1-(2-ptosyloxyethyl)indene, 3-(3-hydroxypropyl(indene, 3-(2-butoxycarbonylethyl)indene, 1-(2- hydroxyethyl)indane, 2-(2-p-tosyloxyethyl)indane, 3-(3-hydroxypropyl)-4,7-dihydroindene, 1 - (3 - p - tosyloxypropyl) - 4,7 - dihydroindane, 1 - hydroxy - 2 - piperidinomethyltetralin, 1- (3 - diethylaminopropyl) - 1 - hydroxytetralin, 1 - (4 - aminobutylidene)tetralin, 1 - (3 - cyanopropylidene)tetralin, 1 - (3 - diethylaminopropyl) - 1 - hydroxy - 5 - methylbenzocycloheptene and 3 - (4 - cyanobutylidene) - benzocycloheptene. Therapeutic compositions for oral or parenteral administration comprise the tetra-oxy compounds of the above Formula I, which have blood pressure lowering and antibiotic activities. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4113726-A |
| priorityDate | 1970-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 271.